Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: elmatador who wrote (77074)	7/30/2011 5:44:47 PM
From: Maurice Winn	1 Recommendation Respond to of 218620

Yes, patents could be abolished, if you think the consequences would be good. But for now, I prefer to leave things as they are, with issued patents being valid. Perhaps further patents could be denied and the existing ones could be left to expire on schedule. Why would anyone develop pharmaceuticals if a copycat could just wait until the chemical was proven, then start producing a copy? That would save a vast fortune in developing and testing. You could live to regret such a decision. Qualcomm has spent a fortune on developing mobile cyberspace technology. I would not have invested my money in the effort if the usual Made in China copycat clones were coming on the market soon after my products. Mqurice